The order of entry effect in prescription (Rx) and over-the-counter (OTC) pharmaceutical drugs

International Journal of Pharmaceutical and Healthcare Marketing

Volumn 2, Issue 1, 2008, Pages 35-46

  Kalyanaram, Gurumurthy ^a  

^a GK Associates   (United States)

Author keywords

Drugs; Market entry; Market system; Pharmaceuticals industry

Indexed keywords

EID: 79959791724     PISSN: 17506123     EISSN: None     Source Type: Journal    
DOI: 10.1108/17506120810865415     Document Type: Article

References (19)

1. Berndt, E.R., Bui, L.T., Reiley, D.H., Urban, G.L. (1995), "Information, marketing and pricing in the U.S. anti-ulcer drug market" in American Economic Review, Vol. 85, No. 2, pp. 100-5.
2. Bond, R.S., Lean, D.F. (1997), Sales, Promotion and Product Differentiation in Two Prescription Drug Markets, Staff Report of the Bureau of Economics of the Federal Trade Commission, Washington, DC.
3. Carpenter, G., Nakamoto, K. (1989), "Consumer preference formation and pioneering advantage" in Journal of Marketing Research, Vol. 26, pp. 285-98.
4. Kalyanaram, G., Urban, G. (1992), "Dynamic effects of the order of entry on market share, trial penetration, and repeat purchases for frequently purchased goods" in Marketing Science, Vol. 11, pp. 235-50.
5. Kalyanaram, G., Robinson, W.T., Urban, G.L. (1995), "Order of market entry: established empirical generalizations, emerging empirical generalizations, and future research" in Marketing Science, Vol. 14, No. 3, pp. G212-21, Part 2 (of 2).
6. Kardes, F.R., Kalyanaram, G. (1992), "Order-of-entry effects on consumer memory and judgment: an information integration perspective" in Journal of Marketing Research, Vol. 29, pp. 343-57.
7. Kardes, F.R., Kalyanaram, G., Chandrashekaran, M., Dornoff, R. (1993), "Brand retrieval, consideration set composition, consumer choice, and the pioneering advantage" in Journal of Consumer Research, Vol. 20, pp. 62-75.
8. King, C. III (2000), "Marketing, product differentiation and competition in the market for antinuclear drugs", Harvard Business School, Boston MA, Working Paper, No. 01-014.
9. Ling, D.C.Y., Berndt, E.R., Kyle, M.K. (2002), "Deregulating direct to consumer marketing of drugs: effects on prescription and over-the-counter product sales", paper presented at the University of Chicago Law School - Medical School Conference, The Regulation of Medical Innovation and Pharmaceutical Markets.
10. Robinson, W.T. (1988), "Marketing mix reaction to entry" in Marketing Science, Vol. 7, No. 3, pp. 368-85.
11. Schmalensee, R. (1982), "Product differentiation advantages of pioneering brands" in American Economic Review, Vol. 11, pp. 349-65.
12. Urban, G.L., Hauser, J.R. (1995), Design and Marketing of New Products, Prentice-Hall, New York, NY.
13. Urban, G.L., Carter, T., Gaskin, S., Mucha, Z. (1986), "Market share rewards to pioneering brands: an empirical analysis and strategic implications" in Management Science, Vol. 32, No. 6, pp. 645-59.
14. Wosinska, M. (2001), "Promoting to multiple agents: the case of direct-to-consumer drug advertising", Department of Economics, University of California-Berkeley, Berkeley, CA.
15. Bowman, D., Gatignon, H. (1995), "Determinants of competitor response time to a new product introduction" in Journal of Marketing Research, Vol. 32, No. 1, pp. 42-53.
16. Eliashherg, J., Jeuland, A.P. (1986), "The impact of competitive entry in a developing market upon dynamic pricing strategies" in Marketing Science, Vol. 5, No. 1, pp. 20-36.
17. Kalyanaram, G., Wittink, D.R. (1994), "Heterogeneity in entry effects between nondurable consumer produce categories" in International Journal of Research in Marketing, Vol. 11, No. 3, pp. 219-31.
18. Pindyck, R.S., Rubinfeld, D.L. (1991), Econometric Models and Economic Forecasts, 3rd ed., McGraw-Hill, New York, NY.
19. Prescott, E.C., Visscher, M. (1977), "Sequential location among firms with foresight" in Bell Journal of Economics, Vol. 8, pp. 378-93.